Verano Holdings (VRNO) Interest & Investment Income (2021 - 2026)
Verano Holdings (VRNO) reported Interest & Investment Income of -$12.3 million for Q1 2026, up 9.22% year-over-year from -$11.3 million in Q1 2025, and up 2.35% quarter-over-quarter from -$12.6 million in Q4 2025.
Verano Holdings (VRNO) Interest & Investment Income (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Interest & Investment Income data on file, last reported at -$12.3 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at -$12.3 million, up 9.22% year-over-year; the trailing twelve-month figure through Mar 2026 was -$52.3 million (up 1.63% YoY), and the FY2025 annual result was -$53.6 million, up 2.14% from the prior year.
- Interest & Investment Income advanced to -$12.3 million in Q1 2026 per VRNO's latest filing, from -$12.6 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at -$10.7 million in Q1 2022 and troughed at -$15.9 million in Q1 2023.
- A 5-year average of -$13.5 million and a median of -$13.6 million in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income sank 113.91% in 2022, then climbed 15.79% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at -$15.3 million in 2022, then advanced by 4.17% to -$14.7 million in 2023, then grew by 14.09% to -$12.6 million in 2024, then increased by 0.23% to -$12.6 million in 2025, then increased by 2.35% to -$12.3 million in 2026.
- Business Quant data shows VRNO's Interest & Investment Income at -$12.3 million in Q1 2026, -$12.6 million in Q4 2025, and -$13.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Verano Holdings | - | - | 98.98 Mn | -12.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.31 Mn |
| Dec 31, 2025 | -12.61 Mn |
| Sep 30, 2025 | -13.21 Mn |
| Jun 30, 2025 | -14.21 Mn |
| Mar 31, 2025 | -13.56 Mn |
| Dec 31, 2024 | -12.64 Mn |
| Sep 30, 2024 | -12.77 Mn |
| Jun 30, 2024 | -14.24 Mn |
| Mar 31, 2024 | -15.11 Mn |
| Dec 31, 2023 | -14.71 Mn |
| Sep 30, 2023 | -15.17 Mn |
| Jun 30, 2023 | -14.01 Mn |
| Mar 31, 2023 | -15.91 Mn |
| Dec 31, 2022 | -15.35 Mn |
| Sep 30, 2022 | -11.79 Mn |
| Jun 30, 2022 | -11.62 Mn |
| Mar 31, 2022 | -10.67 Mn |
| Dec 31, 2021 | -8.96 Mn |
| Sep 30, 2021 | -8.11 Mn |
| Jun 30, 2021 | -5.43 Mn |